» Articles » PMID: 10582772

Insulin-like Growth Factor I: an Attractive Option for Chronic Heart Failure?

Overview
Journal Drugs Aging
Specialties Geriatrics
Pharmacology
Date 1999 Dec 3
PMID 10582772
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic congestive heart failure is a syndrome with a poor prognosis. Currently, the only therapy providing the possibility of long term survival is heart transplantation. Therefore, new therapeutic strategies continue to be investigated. One such new approach may be the application of recombinant human insulin-like growth factor (IGF)-1. IGF-1 has both acute and long term cardiovascular effects. Acute administration of IGF-1 resulted in a reduction in afterload and positive inotropic effects in patients with heart failure. In vitro and animal studies have demonstrated that IGF-1 can stimulate myofibril formation. In addition, IGF-1 administration has beneficial metabolic effects. The benefits of prolonged IGF-1 therapy have yet to be investigated.

Citing Articles

Change of p16(INK4a) and PCNA protein expression in myocardium after injection of hIGF-1 gene modified skeletal myoblasts into post-infarction rats.

Gao Y, Lu Y, Mi S, Liu X, Su G, Rong S J Huazhong Univ Sci Technolog Med Sci. 2008; 28(4):396-400.

PMID: 18704299 DOI: 10.1007/s11596-008-0406-0.


"AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation.

Sussman M Trends Cardiovasc Med. 2007; 17(7):235-40.

PMID: 17936205 PMC: 2083554. DOI: 10.1016/j.tcm.2007.08.003.

References
1.
Gluckman P, Guan J, Beilharz E, Klempt N, Klempt M, Miller O . The role of the insulin-like growth factor system in neuronal rescue. Ann N Y Acad Sci. 1993; 692:138-48. DOI: 10.1111/j.1749-6632.1993.tb26212.x. View

2.
Flyvbjerg A, JORGENSEN K, Marshall S, Orskov H . Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. Am J Physiol. 1991; 260(4 Pt 1):E568-74. DOI: 10.1152/ajpendo.1991.260.4.E568. View

3.
Winterhalter K, Schmid C, FROESCH E, Zapf J . Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology. 1994; 135(6):2558-67. DOI: 10.1210/endo.135.6.7527334. View

4.
Donath M, Zapf J, Eppenberger-Eberhardt M, FROESCH E, Eppenberger H . Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci U S A. 1994; 91(5):1686-90. PMC: 43228. DOI: 10.1073/pnas.91.5.1686. View

5.
NIKKILA E, PELKONEN R . Serum lipids in acromegaly. Metabolism. 1975; 24(7):829-38. DOI: 10.1016/0026-0495(75)90129-8. View